Multicentric assessment of the efficacy and tolerability of dihydroartemisinin-piperaquine compared to artemether-lumefantrine in the treatment of uncomplicated Plasmodium falciparum malaria in sub-Saharan Africa.
about
Dihydroartemisinin/Piperaquine: a review of its use in the treatment of uncomplicated Plasmodium falciparum malariaeditDihydroartemisinin-piperaquine for treating uncomplicated Plasmodium falciparum malariaThe effect of dosing regimens on the antimalarial efficacy of dihydroartemisinin-piperaquine: a pooled analysis of individual patient dataDoes the Use of Dihydroartemisinin-Piperaquine in Treating Patients with Uncomplicated falciparum Malaria Reduce the Risk for Recurrent New falciparum Infection More Than Artemether-Lumefantrine?Surveillance of artemether-lumefantrine associated Plasmodium falciparum multidrug resistance protein-1 gene polymorphisms in TanzaniaComparative impacts over 5 years of artemisinin-based combination therapies on Plasmodium falciparum polymorphisms that modulate drug sensitivity in Ugandan childrenArtemisinin-based combination therapies are efficacious and safe for treatment of uncomplicated malaria in HIV-infected Ugandan childrenIn vitro piperaquine susceptibility is not associated with the Plasmodium falciparum chloroquine resistance transporter geneMultinormal in vitro distribution of Plasmodium falciparum susceptibility to piperaquine and pyronaridine.Monitoring the efficacy and safety of three artemisinin based-combinations therapies in Senegal: results from two years surveillance.Plasmodium falciparum susceptibility to standard and potential anti-malarial drugs in Dakar, Senegal, during the 2013-2014 malaria season.Efficacy and Safety of Artesunate-Amodiaquine versus Artemether-Lumefantrine in the Treatment of Uncomplicated Plasmodium falciparum Malaria in Sentinel Sites across Côte d'Ivoire.Prevalence of molecular markers of Plasmodium falciparum drug resistance in Dakar, Senegal.Sequential combined treatment with allopurinol and benznidazole in the chronic phase of Trypanosoma cruzi infection: a pilot study.In vitro sensitivities of Plasmodium falciparum isolates from the China-Myanmar border to piperaquine and association with polymorphisms in candidate genes.A randomized trial of artemether-lumefantrine and dihydroartemisinin-piperaquine in the treatment of uncomplicated malaria among children in western KenyaThe emerging threat of artemisinin resistance in malaria: focus on artemether-lumefantrine.Comparison of anti-malarial drugs efficacy in the treatment of uncomplicated malaria in African children and adults using network meta-analysis.Possible clinical failure of artemether-lumefantrine in an italian traveler with uncomplicated falciparum malaria.Coartem(®): a decade of patient-centric malaria management.Antimalarial chemotherapy: orally curative artemisinin-derived trioxane dimer esters.Malaria-infected mice live until at least day 30 after a new artemisinin-derived thioacetal thiocarbonate combined with mefloquine are administered together in a single, low, oral dose.Standby emergency treatment of malaria in travelers: experience to date and new developments.The survival times of malaria-infected mice are prolonged more by several new two-carbon-linked artemisinin-derived dimer carbamates than by the trioxane antimalarial drug artemether.Use of artemether-lumefantrine to treat malaria during pregnancy: what do we know and need to know?Choreoathetosis - an unusual adverse effect of dihydroartemisinin-piperaquine: a case report.
P2860
Q21032449-C92A559C-D082-4F7E-A1C4-4D5F97BFAC7BQ24201077-46A73CDE-1386-441C-9D20-9DC1CFFBA8A7Q26822489-EA9B8CCF-C54E-4909-B054-5EEFA031902FQ33874069-3014DD8F-25C3-462F-A114-0A30BC77209AQ33905089-62F2CC9C-8338-47DA-A77A-2E947F9F6D60Q33947834-9971423B-BD81-4678-8317-7E2CE67AEB9DQ34137766-69CE68AF-E3CF-4EAE-AD15-CB3234510106Q34478084-6C2439B1-E932-496C-A1F1-D6BE240C3CFDQ35068138-2504AC98-CA67-42F8-9938-DB01108C50F1Q35071899-8CD27333-3B84-4594-923A-A594E8F544D2Q35101288-CD6FE594-2E43-48D6-896B-34B6F95FDCA6Q35996318-BA97AC5E-8DE5-407C-9960-E44CDB857F9CQ36316217-5D4B4968-4B43-4C86-A815-BC42B6800039Q36526649-DF49C3C8-A342-45BA-B199-C5E42C7517A8Q36757694-E785C126-621E-4CF0-8DE5-FED7CBF38FC1Q37042465-ED57D234-C8DC-4CC4-9DFA-4B00194F3256Q38529669-806DB3AA-FC30-495E-9CDF-5ADFC4F39FC1Q38642887-11DE7997-AC31-4E17-B0BA-19D6B0F078E0Q39022017-531F92AF-DE3D-4E5B-9C48-58E812EC6AF3Q39042892-EDEE8030-F5A8-419B-9235-2FA4FD1DA335Q41614007-A1C6385F-0988-4C31-87A4-2A644B9CAE42Q41920854-5BE18E96-0E91-4CCF-BBD1-80D10F248924Q41929207-3A8472D1-D694-41D6-AFA1-35E1CA2AA6CBQ42000397-1A5143FC-5AF0-4DF9-ACBD-C5B2B235ED3DQ42712939-3C1445BC-2AF9-43C2-B11E-81089506A0C1Q47126784-1DE3FD5D-60DE-4C06-8EB8-0AA66603E6AB
P2860
Multicentric assessment of the efficacy and tolerability of dihydroartemisinin-piperaquine compared to artemether-lumefantrine in the treatment of uncomplicated Plasmodium falciparum malaria in sub-Saharan Africa.
description
2011 nî lūn-bûn
@nan
2011 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Multicentric assessment of the ...... malaria in sub-Saharan Africa.
@ast
Multicentric assessment of the ...... malaria in sub-Saharan Africa.
@en
type
label
Multicentric assessment of the ...... malaria in sub-Saharan Africa.
@ast
Multicentric assessment of the ...... malaria in sub-Saharan Africa.
@en
prefLabel
Multicentric assessment of the ...... malaria in sub-Saharan Africa.
@ast
Multicentric assessment of the ...... malaria in sub-Saharan Africa.
@en
P2093
P2860
P50
P921
P356
P1433
P1476
Multicentric assessment of the ...... malaria in sub-Saharan Africa.
@en
P2093
Albert Same-Ekobo
Babacar Faye
Jean-Bedel Evi
Mariama Diatta
Moor V Ama
Moussa Koné
Richard R Kassi
Serge A Oga
Thomas Kuete
Vincent Djohan
P2860
P2888
P356
10.1186/1475-2875-10-198
P577
2011-07-20T00:00:00Z
P5875
P6179
1006982726